-+ 0.00%
-+ 0.00%
-+ 0.00%

BioVie Completes Enrollment for Phase 2 SUNRISE-PD Trial Testing Bezisterim in Early Parkinson’s Disease

Reuters·01/08/2026 13:02:58

Please log in to view news